This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss
For any queries, please contact Customer Services or your Account Manager. Dismiss
News & Analysis (1201)
-
March 03, 2026 | Official Statement IBM's proposal to acquire Confluent receives Australian regulatory approval
Sections: DealRisk® and Mergers and Acquisitions
-
March 02, 2026 | Official Statement Japan state-backed chipmaker Rapidus names 32 private-sector investors
Sections: Artificial Intelligence and State Aid
-
February 11, 2026 | Insight AI could rework regulators' confidential advice for wider use, UK lawmakers told
Sections: Artificial Intelligence
Get the inside track, with MLex
With a global network of expert journalists digging deep into the areas of risk that matter to your business and clients—and the highest standards of impartiality—you can have complete trust in MLex to keep you ahead of the regulatory curve.
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from specialists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
TRY MLEX FREE FOR 14 DAYS
View full search results
Already a subscriber? Click here to login